Jushi Holdings Inc. (JUSH) company profile
Close on Oct 19, 2026Market cap $98.11MP/E –Yield –
About Jushi
Medicinal Chemicals & Botanical Products, SIC 2833
The company is a vertically integrated cannabis operator in the United States that cultivates, processes, distributes, and sells cannabis products. Its operations encompass retail dispensaries and wholesale distribution to licensed third parties. The product catalog includes dried flower, pre-rolls, vaporizers, concentrates, infused edibles such as gummies and chocolates, tinctures, capsules, and topicals. It also supplies bulk raw materials to other manufacturers. The company serves both registered medical patients and adult-use recreational consumers.
Geographically, the company maintains operations across eight U.S. states: California, Illinois, Massachusetts, Nevada, New Jersey, Ohio, Pennsylvania, and Virginia. Its retail footprint includes forty-two operational dispensaries, comprising twenty-four medical and eighteen adult-use storefronts primarily under the Beyond Hello, Nature’s Remedy, and NuLeaf banners. The company also operates specialized cultivation and manufacturing facilities in Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia. The provided report does not state the location of the corporate headquarters.
Summary of the business section of Jushi's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Jushi Holdings Inc.
- Headquarters
- Boca Raton, FL
- Address
- 301 Yamato Road, Suite 3250 33431
- Phone
- (561) 617-9100
- Website
- jushico.com
- Employees
- 1,288, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- Macias Gini & OConnell LLP, Irvine, California
Stock & identifiers
- Ticker
- JUSH
- Exchange
- OTC
- IPO date
- Jun 18, 2019
- Shares outstanding
- 200M, Oct 22, 2026
- Public float
- $59.40M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1909747
- CUSIP
- 48214U104
- ISIN
- CA48214U1049
- FIGI
- BBG00PGGBDN5
- Share class FIGI
- BBG001T0NHJ2
- EIN
- 98-1547061
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| James Cacioppo | Chief Executive Officer, Director | 16,938,283 |
| Louis Jon Barack | President | 2,928,773 |
| Michelle O. Mosier | Chief Financial Officer | 147,733 |
| Benjamin Cross | Director | 239,080 |
| Stephen Monroe | Director | 153,684 |
| Bill Wafford | Director | – |
| Marina Hahn | Director | 17,301 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Option awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| James Cacioppo Chief Executive Officer | $1.05M | $1.80M | – | $19.41K | $2.87M | -19% |
| Louis Jonathan Barack President, Chief Revenue Officer and Corporate Secretary | $450.02K | $360.00K | $188.86K | $35.55K | $1.03M | +12% |
| Michelle Mosier Chief Financial Officer and Chief Accounting Officer | $425.02K | $212.50K | $113.32K | $18.77K | $769.60K | +8% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 1,288 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 15, 2024 | Late filing | Notification of late filing |
| Apr 25, 2023 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 31, 2023 | Late filing | Notification of late filing |
| Nov 15, 2022 | Late filing | Notification of late filing |
See a number that looks wrong?